Birdwatch Archive

Birdwatch Note

2023-03-06 08:25:20 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

The deworming medicine ivermectin’s perceived efficacy against covid-19 is strongest in places with a high prevalence of parasitic worms and lowest in places with a low prevalence of worms. https://www.economist.com/graphic-detail/2021/11/18/ivermectin-may-help-covid-19-patients-but-only-those-with-worms https://doi.org/10.1001/jamanetworkopen.2022.3079

Written by C966E0BA5803EDA2B9ADEA1A226B5D5FB13629349A2D9A920F01C5137F8AF13B
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1632547243621244929

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1632658608826761221
  • noteId - 1632658608826761221
  • participantId - C966E0BA5803EDA2B9ADEA1A226B5D5FB13629349A2D9A920F01C5137F8AF13B
  • noteAuthorParticipantId -
  • createdAtMillis - 1678091120332
  • tweetId - 1632547243621244929
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 0
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 0
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • The deworming medicine ivermectin’s perceived efficacy against covid-19 is strongest in places with a high prevalence of parasitic worms and lowest in places with a low prevalence of worms. https://www.economist.com/graphic-detail/2021/11/18/ivermectin-may-help-covid-19-patients-but-only-those-with-worms https://doi.org/10.1001/jamanetworkopen.2022.3079

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2023-03-06 08:25:20 UTC
(1678091120332)
1969-12-31 23:59:59 UTC
(-1)
2023-03-07 02:11:29 UTC
(1678155089929)
NEEDS_MORE_RATINGS 1969-12-31 23:59:59 UTC
(-1)

Note Ratings

rated at rated by
2023-03-06 16:28:33 -0600 07618372108E8FBA8439DE6979ED24BBCB38FE3AD0A1C3F447F6F35B4518DE52 Rating Details
2023-03-06 02:43:13 -0600 0BD4990BF3255997269B09B79D8F410C961E941E8728A047A9F5A3FF779F297B Rating Details
2023-03-06 06:28:57 -0600 0D476FB8162A0B894FADC488B9348FFA9313C980B22262F5BC4C4D30F5AA0BC0 Rating Details
2023-03-06 10:48:19 -0600 2425899C10B7F1EBDCBC74B78BC706A6C13CF591FA38668E355D38E05C6D4611 Rating Details
2023-03-06 20:45:04 -0600 25BD17E757358BE19B3B09735A245F6171895FD5E38601E2ED519B620E81C26D Rating Details
2023-03-06 03:09:50 -0600 2A2E9804C4A4513DD489F1EB69457433A630CBEF15FB0F90E564761793906B22 Rating Details
2023-03-06 05:58:58 -0600 2A4169EE19A8A01657FC32ACA31E49627C4645D25E9BB4924CCFEEF066D6E9DD Rating Details
2023-03-06 08:49:29 -0600 34BC1E89C4723C2FD1C55D5F18AA5914BF41C2C20256EDDC887AAF53C41280D7 Rating Details
2023-03-06 21:04:38 -0600 3F9C6BC33A055DDD557A3C2A0D1F7224D73DA767CBD3FAA473F5640A1804CDE1 Rating Details
2023-03-06 17:23:51 -0600 4AED698DA1A72D41B593D8FBF757093E165686BC7C603307D38D67D811EB528C Rating Details
2023-03-08 08:24:17 -0600 6D726319A4D8C972AAFB7B0A9F17D799D0F2BA4003BFDF57F7F8D6A2D8477C4C Rating Details
2023-03-06 03:12:54 -0600 71A8D089BB7143D7CFA04A0D7EEF5C32B3B2901386875FDE172BA7A711F2ADB9 Rating Details
2023-03-06 07:47:16 -0600 7554BE30DC1ACBA237371B5EFA9AFEE56A40F40178D64EB403F2D35E5AB5AD31 Rating Details
2023-03-06 20:42:37 -0600 833B4E6289EB447D755F4C2C685565BCD73BA864A84CD9BC3D1B74F0E87ADDB6 Rating Details
2023-03-06 04:35:58 -0600 92E293F56399BE843C7477FBBE4E556A7FF6D3698387C3CB37720C532C03C714 Rating Details
2023-03-06 06:34:05 -0600 B30C49543C7930381E699C69D5674B291D442BCAD367E679119A96A11CC39FDE Rating Details
2023-03-06 05:56:20 -0600 B5FEE1C7F02671E2466AE0184315222BE9F827034DA0D608839BE86F8B7D554A Rating Details
2023-03-06 02:37:34 -0600 C264DE323534A3FA02C69D31AE0F5F8955DFFB0B38766C67C853DF5390926F1F Rating Details
2023-03-06 09:07:14 -0600 C378931E048482D2BFDF00DC95644D6377CBCB812C79FF87D77B5E48595B3DA3 Rating Details
2023-03-06 02:27:25 -0600 C8AD4B40628824B6C5790A9631BDBF0E9B3BEF0D0BEDCDED0361EE04827DD458 Rating Details
2023-03-06 03:15:05 -0600 CE2DE647C2D2D1EE3738900B91EB4094D8F06FEA3FCF4D00EFC4D49B276FEC24 Rating Details
2023-03-06 14:10:24 -0600 D769B99767C47C7760631B2EAAB019F86067C8391A5E06EFBEFA2DBA142FFB5C Rating Details
2023-03-06 10:30:33 -0600 DA9BF26AEA5A705DD446141ECBBED8645C347AFC937075C711B4B4991AD30CCE Rating Details
2023-03-06 06:29:35 -0600 E12FAE48FEB7596F4B0B7805461337A216695A1136840F9A8A1FA4EB27E9B89A Rating Details
2023-03-06 16:29:30 -0600 E24487233FBB323097BC45A9E137296A05633D9329BD346B328C78ED070D6570 Rating Details
2023-03-06 12:05:21 -0600 E7D67FC356CCE8E77BDADE4882853DBBAEEA238F6E9BE067767C58E137EF3D51 Rating Details
2023-03-06 09:28:49 -0600 EC2E51AE8C64AE6C0C58E504DFB75E133ECF8F5D0FAC60A72EFC1A51DC264969 Rating Details
2023-03-06 09:17:09 -0600 F0E7A7715CD688B11EBEF69CA1FDF5B1A49B556B0140E2216A9637B9ED251F2E Rating Details
2023-03-06 02:28:11 -0600 FD5EE4582645F55BDD6FE532405C3E5432B90B7EB9694B61F2FAFC76D2302567 Rating Details
2023-03-06 21:41:22 -0600 FD89EFB54BF22A6038EFA17EB32EA5B7D16091743F333AEDBD3DCD657161FDC2 Rating Details
2023-03-14 12:59:25 -0500 Rating Details
2023-03-14 02:30:37 -0500 Rating Details
2023-03-14 00:21:25 -0500 Rating Details
2023-03-13 15:01:28 -0500 Rating Details
2023-03-14 23:36:19 -0500 Rating Details
2023-03-14 23:17:14 -0500 Rating Details
2023-03-14 23:16:57 -0500 Rating Details
2023-03-14 23:12:35 -0500 Rating Details
2023-03-14 22:42:02 -0500 Rating Details
2023-03-16 14:26:16 -0500 Rating Details
2023-03-16 11:46:06 -0500 Rating Details
2023-03-17 09:12:43 -0500 Rating Details
2023-03-17 06:00:21 -0500 Rating Details
2023-04-06 16:56:50 -0500 Rating Details
2023-03-06 06:28:57 -0600 Rating Details
2023-03-06 10:48:19 -0600 Rating Details
2023-03-06 03:12:54 -0600 Rating Details
2023-03-06 02:43:13 -0600 Rating Details
2023-03-06 21:41:22 -0600 Rating Details
2023-03-14 23:17:14 -0500 Rating Details
2023-03-06 03:09:50 -0600 Rating Details
2023-03-06 05:58:58 -0600 Rating Details
2023-03-06 16:28:33 -0600 Rating Details
2023-03-06 21:04:38 -0600 Rating Details
2023-03-06 20:45:04 -0600 Rating Details
2023-03-06 06:29:35 -0600 Rating Details
2023-03-06 05:56:20 -0600 Rating Details
2023-03-06 09:07:14 -0600 Rating Details
2023-03-14 00:21:25 -0500 Rating Details
2023-03-13 15:01:28 -0500 Rating Details
2023-03-14 23:16:57 -0500 Rating Details
2023-03-14 12:59:25 -0500 Rating Details
2023-03-06 09:28:49 -0600 Rating Details
2023-03-06 08:49:29 -0600 Rating Details
2023-03-06 17:23:51 -0600 Rating Details
2023-03-14 23:12:35 -0500 Rating Details
2023-03-06 12:05:21 -0600 Rating Details
2023-03-06 07:47:16 -0600 Rating Details
2023-03-06 06:34:05 -0600 Rating Details
2023-03-17 06:00:21 -0500 Rating Details
2023-03-16 11:46:06 -0500 Rating Details
2023-03-14 02:30:37 -0500 Rating Details
2023-03-06 10:30:33 -0600 Rating Details
2023-03-17 09:12:43 -0500 Rating Details
2023-03-06 02:37:34 -0600 Rating Details
2023-03-06 16:29:30 -0600 Rating Details
2023-03-16 14:26:16 -0500 Rating Details
2023-04-06 16:56:50 -0500 Rating Details
2023-03-06 04:35:58 -0600 Rating Details
2023-03-06 20:42:37 -0600 Rating Details
2023-03-08 08:24:17 -0600 Rating Details
2023-03-14 23:36:19 -0500 Rating Details
2023-03-06 09:17:09 -0600 Rating Details
2023-03-06 14:10:24 -0600 Rating Details
2023-03-14 22:42:02 -0500 Rating Details
2023-03-06 02:28:11 -0600 Rating Details
2023-03-06 03:15:05 -0600 Rating Details
2023-03-06 02:27:25 -0600 Rating Details